Search - tctmd.com

$The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...$

Presentation TCT 2013

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Elazer Edelman, Stefan Verheye

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

Presentation TCT 2013

Impact of Ad Hoc Percutaneous Coronary Intervention with Drug-Eluting Stent in Angina Patients

Presenter: Young-Hak Kim, Duk-Woo Park, Jung-Min Ahn, Gyung-Min Park, Hae Geun Song, Jong-Young Lee, Won-Jang Kim, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park

January 31, 2013

Advertisement

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB EXTEND: BVS Safe Out to 3 Years

Stable Angina: PCI vs CABG vs OMT

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

Novel Ischemia Measurement Strategies Show Potential vs. FFR

Misperceptions Persist Regarding ‘Inappropriate’ PCI

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Stable Angina: PCI vs. CABG vs. OMT

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Impact of Ad Hoc Percutaneous Coronary Intervention with Drug-Eluting Stent in Angina Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content